Latest news and views from PBD Biotech about the detection, identification and eradication of tuberculosis and related mycobacterial diseases.
Loading...
October 25, 2018
PBD Biotech Limited is pleased to announce that its key technology patent has been granted by the European Patent Office.
PBD Biotech Limited is pleased to announce that its key technology patent has been granted by the European Patent Office.
August 7, 2018
Following PBD Biotech’s successful seed funding round, CEO Dr Berwyn Clarke spoke to Growth Business, the leading media portal for entrepreneurs, about the start-up’s strategic approach to securing the right investment for phage-based technology.
Following PBD Biotech’s successful seed funding round, CEO Dr Berwyn Clarke spoke to Growth Business, the leading media portal for...
August 24, 2017
PBD Biotech Ltd is delighted to announce that it has successfully completed an over-subscribed seed investment round composed of angel investment from Cambridge Agritech Ltd and Anglia Capital Group.
August 24, 2017
PBD Biotech Ltd is delighted to announce that it has successfully completed an over-subscribed seed investment round composed of angel...
July 26, 2016
Reported by Dr Catherine Rees at Viruses of Microbes 2016 Conference.
Reported by Dr Catherine Rees at Viruses of Microbes 2016 Conference.
May 19, 2016
A research paper has been published in Virulence journal, by Benjamin Swift, Thomas Convery and Catherine Rees: 'Evidence of Mycobacterium tuberculosis complex bacteraemia in intradermal skin test positive cattle detected using phage-RPA'.
A research paper has been published in Virulence journal, by Benjamin Swift, Thomas Convery and Catherine Rees: 'Evidence of Mycobacterium...